# Ernexa Therapeutics Inc.: Form 8-K, filed Jun 9, 2017

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2017-06-09
- Accepted by EDGAR: Jun 9, 2017, 16:36 ET
- Period: 2017-06-08
- Accession: 0001493152-17-006434
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315217006434/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315217006434/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315217006434/form8-k.htm

Filed Jun 9, 2017.
Source: SEC EDGAR, the filing index for accession 0001493152-17-006434. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.